Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens

Journal Title: Medpulse International Journal of Biochemistry - Year 2018, Vol 5, Issue 3

Abstract

Background: Heart failure is a complex clinical syndrome, impairing the ability of the cardiac ventricles to fill with or eject blood. Drug therapy for Chronic Heart Failure (CHF) is aimed at providing symptomatic relief and has to be continued indefinitely. Currently Angiotensin Converting Enzyme Inhibitor (ACEI), beta blocker and diuretic form the basis of treatment for CHF. These drugs can cause a wide array of electrolyte disturbances which frequently result in potentially dangerous complications. Early identification of these electrolyte disturbances and knowledge of the pathophysiological mechanisms underlying them will help in the effective management of these patients, when complex combinations of drugs are used. Objectives: 1.To estimate the serum sodium and potassium levels in ‘stable’ Chronic Heart Failure (CHF) patients on treatment. 2. To study the impact of Angiotensin Converting Enzyme inhibitors (ACEI), beta blockers and spironolactone with or without furosemide on serum sodium and potassium levels in stable CHF patients receiving the above drugs. Materials and Methods: A cross-sectional study was conducted on 120 stable chronic heart failure patients. In this, 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers, spironolactone and furosemide, while the other 60 patients were under Angiotensin Converting Enzyme inhibitors(ACEI), beta blockers and spironolactone regimen. Serum creatinine, sodium and potassium levels were analyzed in both the group. Conclusion: Majority of the drugs used in the treatment of CHF cause electrolyte disturbances. Hyponatremia in patients receiving all the four drugs and hyperkalemia in patients receiving only three drugs, was observed in our study.

Authors and Affiliations

A Khadeja Bi, S Suganya, Jnankumar Chaudhuri

Keywords

Related Articles

Transfusion associated hemoglobinopathy

Transfusion associated hemoglobinopathy occurs when the donor is an asymptomatic carrier of the abnormal haemoglobin and such blood is transfused to a patient. Abnormal peaks are seen in High Performance Liquid Chromatog...

Correlation between serum PON-1 activity and lipid profile in diabetes mellitus

Background: PON1 has detoxification activity in atherosclerotic processes. Serum PON1 activity has been shown to be reduced in atherogenesis. Thus, estimation of PON activity in diabetes mellitus is being valuable in pre...

Comparison of serum leptin concentration and electrolytes in pre-eclampsia and normal pregnancy

Background: Preeclampsia is one of the leading causes of maternal as well as perinatal morbidity and mortality. Studies have shown that leptin has also been implicated in the pathogenesis of many of the maternal features...

Prevalence of metabolic syndrome and its components among young adults at a tertiary care hospital in Puducherry

Background: Metabolic syndrome refers to a group of risk factors that increase the risk for the development of type 2 diabetes mellitus and cardiovascular diseases. The prevalence of metabolic syndrome is increasing worl...

Comparative study of electrolyte levels with various level of HbA1C in diabetes mellitus patients

Objective: The aim of this study is to estimate of electrolyte levels in patient with diabetes mellitus and compare the result among the various levels of HbA1C and also to find out the correlation between electrolytes a...

Download PDF file
  • EP ID EP486163
  • DOI 10.26611/10025310
  • Views 136
  • Downloads 0

How To Cite

A Khadeja Bi, S Suganya, Jnankumar Chaudhuri (2018). Electrolyte abnormalities in chronic heart failure patients on treatment with two different drug regimens. Medpulse International Journal of Biochemistry, 5(3), 116-119. https://europub.co.uk/articles/-A-486163